Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $23,313 | 12 | 31.2% |
| Travel and Lodging | $18,489 | 71 | 24.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,400 | 6 | 20.6% |
| Grant | $6,200 | 1 | 8.3% |
| Food and Beverage | $4,533 | 71 | 6.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,162 | 3 | 4.2% |
| Honoraria | $2,500 | 1 | 3.3% |
| Education | $1,228 | 16 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $52,880 | 107 | $0 (2020) |
| Allergan Inc. | $10,953 | 35 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $7,403 | 19 | $0 (2017) |
| SCYNEXIS, Inc. | $1,050 | 1 | $0 (2022) |
| Sprout Pharmaceuticals, Inc. | $1,000 | 1 | $0 (2018) |
| TherapeuticsMD, Inc. | $402.63 | 3 | $0 (2020) |
| Astellas Pharma US Inc | $249.99 | 2 | $0 (2023) |
| Novo Nordisk Inc | $245.15 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $211.33 | 3 | $0 (2024) |
| Duchesnay USA Incorporated | $165.14 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $390.16 | 5 | Novo Nordisk Inc ($245.15) |
| 2023 | $241.32 | 3 | Astellas Pharma US Inc ($125.00) |
| 2022 | $1,175 | 2 | SCYNEXIS, Inc. ($1,050) |
| 2021 | $128.07 | 4 | Lupin Inc. ($128.07) |
| 2020 | $3,547 | 5 | AMAG Pharmaceuticals, Inc. ($3,409) |
| 2019 | $7,022 | 18 | AMAG Pharmaceuticals, Inc. ($6,757) |
| 2018 | $18,783 | 31 | AMAG Pharmaceuticals, Inc. ($17,532) |
| 2017 | $43,537 | 113 | AMAG Pharmaceuticals, Inc. ($25,181) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $100.06 | General |
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $52.78 | General |
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $44.95 | General |
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $162.37 | General |
| 09/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 11/17/2023 | Antares Pharma, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug) | Food and Beverage | In-kind items and services | $66.32 | General |
| Category: Womens Health | ||||||
| 09/28/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 10/13/2022 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 02/23/2022 | SCYNEXIS, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 10/09/2021 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | In-kind items and services | $53.10 | General |
| Category: Obstetrics/Gynecology | ||||||
| 10/09/2021 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Obstetrics/Gynecology | ||||||
| 10/08/2021 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | In-kind items and services | $52.88 | General |
| Category: Obstetrics/Gynecology | ||||||
| 10/08/2021 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | Cash or cash equivalent | $8.81 | General |
| Category: Obstetrics/Gynecology | ||||||
| 03/07/2020 | TherapeuticsMD, Inc. | — | Food and Beverage | In-kind items and services | $137.39 | General |
| 01/08/2020 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Travel and Lodging | Cash or cash equivalent | $2,176.18 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 01/08/2020 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Travel and Lodging | Cash or cash equivalent | $1,041.60 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 01/08/2020 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Travel and Lodging | Cash or cash equivalent | $143.14 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 01/08/2020 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Travel and Lodging | Cash or cash equivalent | $48.34 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 10/26/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $27.01 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 09/27/2019 | TherapeuticsMD, Inc. | — | Food and Beverage | In-kind items and services | $122.62 | General |
| 09/26/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Education | In-kind items and services | $32.09 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 09/26/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $18.32 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 09/24/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $46.15 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 06/26/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Consulting Fee | Cash or cash equivalent | $837.55 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
About Dr. Sharon Parish, MD
Dr. Sharon Parish, MD is a Internal Medicine healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376633107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharon Parish, MD has received a total of $74,824 in payments from pharmaceutical and medical device companies, with $390.16 received in 2024. These payments were reported across 181 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($23,313).
Practice Information
- Specialty Internal Medicine
- Location White Plains, NY
- Active Since 10/13/2006
- Last Updated 04/24/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376633107
Products in Payments
- INTRAROSA (Drug) $14,269
- BREMELANOTIDE (Drug) $13,756
- ADDYI (Drug) $7,489
- VYLEESI (Drug) $4,279
- ESTRACE CREAM (Drug) $1,285
- MAKENA (Drug) $961.12
- Osphena (Drug) $165.14
- SOLOSEC (Drug) $128.07
- Veozah (Drug) $125.00
- Mirena (Drug) $66.32
- TLANDO (Drug) $50.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in White Plains
Tomrul Tuzel, M.d, M.D
Internal Medicine — Payments: $113,652
Despoina Michailidou, Md, MD
Internal Medicine — Payments: $73,621
Daniel Wang, M.d, M.D
Internal Medicine — Payments: $19,656
Dr. Breta Boots, Do, DO
Internal Medicine — Payments: $9,255
Dr. Vivian Volterre, M.d, M.D
Internal Medicine — Payments: $7,003
Todd Shinnick, M.d, M.D
Internal Medicine — Payments: $6,113